QuidelOrtho Corp. QDEL

NAS: QDEL | ISIN: US74838J1016   15/12/2025
29,06 USD (+0,90%)
(+0,90%)   15/12/2025

24 november 2025 · QuidelOrtho To Participate In Upcoming Investor Conferences · Persbericht

20 november 2025 · The Power of Prevention: Detecting Diabetes Before It Strikes · Persbericht

5 november 2025 · QuidelOrtho Reports Third Quarter 2025 Financial Results · Persbericht

3 november 2025 · QuidelOrtho Receives FDA 510(k) Clearance for VITROS™ Immunodiagnostic Products hs Troponin I Assay · Persbericht

24 oktober 2025 · Informatics Illuminated: Science Bytes Podcast Explores the Power Behind Smarter Diagnostics · Persbericht

22 oktober 2025 · QuidelOrtho to Report Third Quarter 2025 Financial Results · Persbericht

17 oktober 2025 · QuidelOrtho Showcases Leadership in Transfusion Medicine at AABB 2025 · Persbericht

25 september 2025 · Through Shades of Illness: Science Bytes Podcast Discusses Why Testing Matters · Persbericht

22 september 2025 · QuidelOrtho Announces Availability of QUICKVUE™ Influenza + SARS Test for Professional Use · Persbericht

28 augustus 2025 · QuidelOrtho to Participate in the Baird 2025 Global Healthcare Conference · Persbericht

21 augustus 2025 · QuidelOrtho Completes Debt Refinancing · Persbericht

21 augustus 2025 · Science Bytes Podcast Explores How Diagnostics Can Help Protect Students and Communities · Persbericht

19 augustus 2025 · QuidelOrtho Welcomes Erich Wolff as Executive Vice President, Strategy & Corporate Development · Persbericht

13 augustus 2025 · QuidelOrtho Launches Certified Analyzer Program · Persbericht

5 augustus 2025 · QuidelOrtho Reports Second Quarter 2025 Financial Results · Persbericht

29 juli 2025 · QuidelOrtho Recognized with Three Awards in 2025 IMV ServiceTrak™ · Persbericht

24 juli 2025 · Urgent Need for Early Detection in Drug Overdose Cases Highlighted in New Podcast · Persbericht

22 juli 2025 · QuidelOrtho to Report Second Quarter 2025 Financial Results · Persbericht

17 juli 2025 · Real Labs, Actual Decisions With Actionable Six Sigma Metrics · Persbericht

14 juli 2025 · Quidelortho And Bühlmann Laboratories Ag Announce Availability Of Fecal Calprotectin (Fcal®) Turbo And Fecal Pancreatic Elastase (Fpela®) Turbo Assays On Vitros™ Systems As A Microtip™ Partnership Assay (Mpa) · Persbericht

Mijn selecties